Top

Journal of Gastrointestinal Surgery

Published in:

01-02-2009 | review article

Quantitative Assessment of Hepatic Function and its Relevance to the Liver Surgeon

Authors: G. Morris-Stiff, D. Gomez, R. Prasad

Published in: Journal of Gastrointestinal Surgery | Issue 2/2009

Abstract

Background

Standard evaluation of patients undergoing hepatic surgery has been through radiological and quantitative determination of liver function. As more complex and extensive surgery is now being performed, often in the presence of cirrhosis/fibrosis or following administration of chemotherapy, it is questioned whether additional assessment may be required prior to embarking on such surgery. The aim of this review was to determine the current knowledge base in relation to the performance of quantitative assessment of hepatic function both pre- and post-operatively in patients undergoing hepatic resectional surgery and liver transplantation.

Methods

An electronic search was performed of the medical literature using the MEDLINE database to identify relevant articles with cross-referencing of all identified papers to ensure full literature capture.

Results and Conclusions

The review has identified a number of different methods of dynamically assessing hepatic function, the most frequently performed being through the use of indocyanine green clearance. With the recent and further anticipated developments in hepatic resectional surgery, it is likely that quantitative assessment will become more widely practiced in order to reduce post-operative hepatic failure and improve outcome.

Lau H, Man K, Fan ST et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997;84:1255–1259. doi:10.1002/bjs.1800840917.PubMedCrossRef

Didolkar MS, Fitzpatrick JL, Elias EG et al. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 1989;169:17–26.PubMed

Takenaka K, Kanematsu T, Fuzuzawa K et al. Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented. World J Surg 1990;14:123–127. doi:10.1007/BF01670561.PubMedCrossRef

Fan ST, Lai ECS, Lo CM, Ng IOL, Wong J. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995;130:198–203.PubMed

Poon RT, Fan ST, Lo CM et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary disease: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004;240:698–710. doi:10.1097/01.sla.0000143808.63039.51.PubMed

Schneider PD. Preoperative assessment of liver function. Surg Clin N Am 2004;84:355–373. doi:10.1016/S0039-6109(03)00224-X.PubMedCrossRef

Okamoto E, Kyo Yamanaka N et al. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984;95:586–592.PubMed

Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986;99:694–701.PubMed

Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–470. doi:10.1053/jhep.2001.22172.PubMedCrossRef

10.

Freeman RB, Wiesner RH, Harper A et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851–858. doi:10.1053/jlts.2002.35927.PubMedCrossRef

11.

Cucchetti A, Ercolani G, Vivarelli M et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 2006;12:966–971. doi:10.1002/lt.20761.PubMedCrossRef

12.

Teh SH, Christein J, Donohue J et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointestinal Surg 2005;9:1207–1215. doi:10.1016/j.gassur.2005.09.008.CrossRef

13.

Cucchetti A, Ercolani G, Cescon M et al. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg 2006;203:670–676. doi:10.1016/j.jamcollsurg.2006.06.018.PubMedCrossRef

14.

Balzan S, Belghiti J, Farges O et al. The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 2005;242:824–828. doi:10.1097/01.sla.0000189131.90876.9e.PubMedCrossRef

15.

Bruix J, Castells A, Bosch J et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018–1022. doi:10.1016/S0016-5085(96)70070-7.PubMedCrossRef

16.

Caesar J, Shaldon S, Chiandussi L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961;21:43–47.PubMed

17.

Prasad KR. Post-hepatectomy liver failure: prevention and management. In: Chattopadhyay (Ed) G.I. surgery annual. New Delhi; 2006: 119–129.

18.

Nagao T, Inoue S, Goto S et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg 1987;205:33–40. doi:10.1097/00000658-198701000-00006.PubMedCrossRef

19.

Yamanaka N, Okamoto E, Priyama T et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 1994;219:342–346. doi:10.1097/00000658-199404000-00003.PubMedCrossRef

20.

Hsia CY, Lui WY, Chau GY et al. Perioperative safety and prognosis in hepatocellular carcinoma patients with impaired liver function. J Am Coll Surg 2000;190:574–579. doi:10.1016/S1072-7515(00)00259-3.PubMedCrossRef

21.

Ishikawa M, Yogita S, Miyake H et al. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma. Hepato-Gastroenterology 2002;49:1625–1631.PubMed

22.

Wakabayashi H, Ishimura K, Izuishi K, Karasawa Y, Maeta H. Evaluation of liver function for hepatic resection for hepatocellular carcinoma in the liver with damaged parenchyma. J Surg Res 2004;116:248–252. doi:10.1016/j.jss.2003.09.015.PubMedCrossRef

23.

Torzilli G, Makuuchi M, Inoue K et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and non-cirrhotic patients. Arch Surg 1999;134:984–992. doi:10.1001/archsurg.134.9.984.PubMedCrossRef

24.

Imamura H, Seyama Y, Kokudo N et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003;138:1198–1206. doi:10.1001/archsurg.138.11.1198.PubMedCrossRef

25.

Noguchi T, Imai T, Mizumoto R. Preoperative assessment of surgical risk of hepatectomy in cirrhotic patients. Hepatogastroenterology 1990;37:165–171.PubMed

26.

Ohwada S, Kawate S, Hamada K et al. Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg 2006;93:339–346. doi:10.1002/bjs.5258.PubMedCrossRef

27.

Bennett JJ, Blumgart LH. Assessment of hepatic reserve prior to hepatic resection. J Hepatobiliary Pancreat Surg 2005;12:10–15. doi:10.1007/s00534-004-0950-3.PubMedCrossRef

28.

Jarnagin WR, Gonen M, Fong YM et al. Improvement in perioperative outcome after hepatic resection. Analysis of 1803 consecutive cases over the past decade. Ann Surg 2002;236:397–407. doi:10.1097/00000658-200210000-00001.PubMedCrossRef

29.

Clements D, McMaster P, Elias E. Indocyanine green clearance in acute rejection after liver transplantation. Transplantation 1988;46:383–385. doi:10.1097/00007890-198809000-00009.PubMedCrossRef

30.

Tsubono T, Todo S, Jabbour N et al. Indocyanine green elimination test in orthotopic liver transplantation. Hepatology 1996;24:1165–1171. doi:10.1002/hep.510240531.PubMedCrossRef

31.

Oellerich M, Burdelski M, Lautz HU et al. Assessment of pretransplant prognosis in patients with cirrhosis. Transplantation 1991;51:801–806. doi:10.1097/00007890-199104000-00013.PubMedCrossRef

32.

Jochum C, Beste M, Penndorf V et al. Quantitative liver function tests in donors and recipients of living donor liver transplantation. Liver Transpl 2006;12:544–549. doi:10.1002/lt.20627.PubMedCrossRef

33.

Lamesch P, Ringe B, Oellerich M et al. Assessment of liver function in the early postoperative period after liver transplantation with ICG, MEGX, and GAL tests. Transplant Proc 1990;22:1539–1541.PubMed

34.

Yamanaka N, Okamoto E, Kato T et al. Usefulness of monitoring the ICG retention rate as an early allograft function in liver transplantation. Transplant Proc 1992;24:1614–1617.PubMed

35.

Plevris J, Khalid R, Dollinger M et al. Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft outcome. J Hepatol 1999;30:142–148. doi:10.1016/S0168-8278(99)80018-X.PubMedCrossRef

36.

Jalan R, Plevris JN, Jalan AR, Finlayson ND, Hayes PV. A pilot study of indocyanine green clearance as an early predictor of graft function. Transplantation 1994;58:196–200.PubMed

37.

Igea J, Nuño J, Lopez-Hervas P et al. Indocyanine green clearance as a marker of graft function in liver transplantation. Transplant Proc 1999;31:2447–2448.PubMedCrossRef

38.

Okochi O, Kaneko T, Sugimoto H et al. ICG pulse spectrophotometry for perioperative function in hepatectomy. J Surg Res 2002;103:109–113. doi:10.1006/jsre.2001.6328.PubMedCrossRef

39.

Sugimoto H, Okochi O, Hirota M et al. Early detection of liver failure after hepatectomy by indocyanine green elimination rate measured by pulse-dye densiometry. J Hepatobiliary Pancreat Surg 2006;13:543–548. doi:10.1007/s00534-006-1114-4.PubMedCrossRef

40.

Diaz S, Perez-Pena J, Sanz J, Olmedilla L, Garutti I, Barrio JM. Haemodynamic monitoring and liver function evaluation by pulsion cold system Z-201 (PCS) during orthotopic liver transplantation. Clin Transplant 2003;17:47–55. doi:10.1034/j.1399-0012.2003.02072.x.PubMedCrossRef

41.

Purcell R, Kruger P, Jones M. Indocyanine green elimination: a comparison of the LiMON and serial blood sampling methods. ANZ J Surg 2006;76:75–77. doi:10.1111/j.1445-2197.2006.03643.x.PubMedCrossRef

42.

Hsieh C-B, Chen C-J, Chen T-W et al. Accuracy of indocyanine green pulse spectrophotometry clearance test for liver function prediction in transplanted patients. World J Gastroenterol 2004;10:2394–2396.PubMed

43.

Hori T, Iida T, Yagi S et al. K_ICG value, a reliable real-time estimator of graft function, accurately predicts outcomes in adult living-donor liver transplantation. Liver Transplantation 2006;12:605–613. doi:10.1002/lt.20713.PubMedCrossRef

44.

Oellerich M, Armstrong VW. The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit 2003;23:81–92. doi:10.1097/00007691-200104000-00001.CrossRef

45.

Lee W-C, Chen M-F. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg 2005;12:23–26. doi:10.1007/s00534-004-0947-y.PubMedCrossRef

46.

Reding R, Wallemacq P, de Ville de Goyet J et al. The unreliability of the lidocaine/monoethylglycinexylidide test for assessment of liver donors. Transplantation 1993;56:323–326. doi:10.1097/00007890-199308000-00012.PubMedCrossRef

47.

Potter JM, Hickman PE, Henderson A, Balderson GA, Lynch SV, Strong RW. The use of the lidocaine-monothylglycinexylidide test in the liver transplant recipient. Ther Drug Monit 1996;18:383–387. doi:10.1097/00007691-199608000-00012.PubMedCrossRef

48.

Freys G, Pottecher T, Calon B et al. Early assessment of transplanted liver function: lignocaine clearance test (MEGX). Eur J Anaesthesiol 1997;14:397–405. doi:10.1046/j.1365-2346.1997.00156.x.PubMedCrossRef

49.

Ercolani G, Grazi GL, Calliva R et al. The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery 2000;127:464–471.PubMed

50.

Zoedler T, Ebener C, Becker H, Roeher HD. Evaluation of liver function tests to predict operatives risks in liver surgery. HPB Surg 1995;9:13–18. doi:10.1155/1995/47538.PubMedCrossRef

51.

Redaelli CA, Dufour J, Wagner M et al. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 2002;235:77–85. doi:10.1097/00000658-200201000-00010.PubMedCrossRef

52.

Nadalin S, Testa G, Malago M et al. Volumetric and functional recovery of the liver after right hepatectomy for living donation. Liver Transpl 2004;10:1024–1029. doi:10.1002/lt.20182.PubMedCrossRef

53.

Yamaoka Y, Wahida M, Manaka D et al. Arterial ketone body ratio as a predictor of donor viability in human liver transplantation. Transplantation 1993;55:92–95. doi:10.1097/00007890-199301000-00018.PubMedCrossRef

54.

Asonuma K, Takaya S, Selby S et al. The clinical significance of the arterial ketone body ratio as an indicator of graft viability in human liver transplantation. Transplantation 1991;51:164–171. doi:10.1097/00007890-199101000-00025.PubMedCrossRef

55.

Egawa H, Shaked A, Konishi Y et al. Arterial ketone body ration in pediatric liver transplantation. Transplantation 1993;55:522–526. doi:10.1097/00007890-199303000-00012.PubMedCrossRef

56.

Kiuchi T, Ozawa K, Yamamoto Y et al. Changes in arterial ketone body ratio in the phase immediate after hepatectomy. Prognostic implications. Arch Surg 1990;125:655–659.PubMed

57.

Asano M, Ozawa K, Tobe T. Postoperative prognosis as related to blood ketone body ratios in hepatectomized patients. Eur Surg Res 1983;15:302–311. doi:10.1159/000128373.PubMedCrossRef

58.

Hanazaki K, Wakabayashi M, Sodeyama H et al. Arterial ketone body ratio does not correlate with ischemic changes during major hepatectomy. Hepatogastroenterology 1998;45:145–149.PubMed

59.

Tsubono T, Tsukada K, Hatakeyama K. Hepatic functional reserve in patients with obstructive jaundice: an assessment by the redox tolerance test. Am J Surg 1995;169:300–303. doi:10.1016/S0002-9610(99)80162-7.PubMedCrossRef

60.

Mori K, Ozawa K, Yamamoto Y et al. Response of hepatic mitochondrial redox state to oral glucose load. Redox tolerance test as a new predictor of surgical risk in hepatectomy. Ann Surg 1990;211:438–446. doi:10.1097/00000658-199004000-00010.PubMedCrossRef

61.

Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K. Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984;95:586–592.PubMed

62.

Kubota K, Makuuchi M, Kusaka K et al. Measurement of liver volume and hepatic reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997;26:1176–1181.PubMed

63.

Shirabe K, Shimada M, Gion T et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999;188:304–309. doi:10.1016/S1072-7515(98)00301-9.PubMedCrossRef

64.

Shoup M, Gonen M, D’Angelica M et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003;7:325–330. doi:10.1016/S1091-255X(02)00370-0.PubMedCrossRef

65.

Yigitler C, Farges O, Kianmanesh R et al. The small remnant liver after major hepatic resection: how common and how relevant. Liver Transpl 2003;9:S18–S25. doi:10.1053/jlts.2003.50194.PubMedCrossRef

66.

Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ. The value of residual liver volume as a predictor of hepatic dysfunction after major liver resection. Gut 2005;54:289–296. doi:10.1136/gut.2004.046524.PubMedCrossRef

67.

Hsieh CB, Yu CY, Tzao C et al. Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection. Eur J Surg Oncol 2006;32:72–76. doi:10.1016/j.ejso.2005.09.003.PubMedCrossRef

68.

Akaki S, Okumura Y, Sasai N et al. Hepatectomy simulation discrepancy between radionucleotide receptor imaging and CT volumetry: influence of decreased unilateral portal venous flow. Ann Nucl Med 2003;17:23–29.PubMedCrossRef

69.

Vauthey J-N, Chaoui A, Do K-A et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000;127:512–519. doi:10.1067/msy.2000.105294.PubMedCrossRef

70.

Azoulay D, Castaing D, Krissat J et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000;232:665–672. doi:10.1097/00000658-200011000-00008.PubMedCrossRef

71.

Hemming AW, Reed AI, Howard RJ et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003;237:686–693. doi:10.1097/00000658-200305000-00011.PubMedCrossRef

72.

Hwang S, Lee SG, Lee YJ et al. Lessons learned from 1000 living donor liver transplantations in a single centre: how to make living donations safe. Liver Transpl 2006;12:920–927.PubMedCrossRef

73.

Paluszkiewicz R, Hevelke P, Zieniewicz K et al. Evaluation of donor’s liver regeneration after left lobe harvesting for living-related liver transplantation. Transplant Proc 2006;38:199–203. doi:10.1016/j.transproceed.2005.12.020.PubMedCrossRef

74.

Marcos A, Fisher RA, Ham JM et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375–1379. doi:10.1097/00007890-200004150-00028.PubMedCrossRef

75.

Kudo M, Vera DR, Stadalnik RC et al. In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve. Am J Gastroenterol 1990;85:1142–1148.PubMed

76.

Kwon AH, Ha-Kawa SK, Uetsuji S, Kamiyama Y, Tanaka Y. Use of technetium 99m diethylenetriamine-pantaacetic acid-galactosyl-human serum albumin liver scintigraphy in the evaluation of preoperative and postoperative hepatic functional reserve for hepatectomy. Surgery 1995;117:429–434. doi:10.1016/S0039-6060(05)80063-7.PubMedCrossRef

77.

Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Tanaka Y. Preoperative determination of the surgical procedure for hepatectomy using technetirum-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 1997;25:426–429. doi:10.1002/hep.510250228.PubMedCrossRef

78.

Fujioka H, Kawashita Y, Kamohara Y et al. Utility of technetium-99m-galactosyl human serum albumin scintigraphy for estimating the functional hepatic reserve. J Clin Gastroenterol 1999;28:329–333. doi:10.1097/00004836-199906000-00009.PubMedCrossRef

79.

Hwang EH, Taki J, Shuke N et al. Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT. J Nucl Med 1999;40:1644–1651.PubMed

80.

Satoh K, Yamamoto Y, Nishiyama Y et al. 99mTc-GSA liver dynamic SPECT for the preoperative assessment of hepatectomy. Ann Nucl Med 2003;17:61–67.PubMedCrossRef

81.

Kwon A-H, Matsui Y, Kaibori M, Ha-Kawa SK. Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin (GSA-Rmax) is useful for judging the safety of hepatic resection. Surgery 2006;140:379–386. doi:10.1016/j.surg.2006.02.011.PubMedCrossRef

82.

Kwon A-H, Matsui Y, Ha-Kawa SK et al. Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography. Am J Gastroenterol 2001;96:541–546. doi:10.1111/j.1572-0241.2001.03556.x.PubMedCrossRef

83.

Hirai I, Kimura W, Fuse A, Suto K, Urayama M. Evaluation of preoperative portal embolization for safe hepatectomy, with special reference to assessment of nonembolized lobe function with 99mTc-GSA SPECT scintigraphy. Surgery 2003;133:495–506. doi:10.1067/msy.2003.138.PubMedCrossRef

84.

Nanashima A, Yamaguchi H, Shibasaki S et al. Relationship between CT volumetry and functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study. Dig Dis Sci 2006;51:1190–1195. doi:10.1007/s10620-006-8031-x.PubMedCrossRef

85.

Kita Y, Miki K, Hirao S et al. Liver allograft functional reserve estimated by total asialoglycoprotein receptor amount using Tc-GSA liver scintigraphy. Transplant Proc 1998;30:3277–3278. doi:10.1016/S0041-1345(98)01027-6.PubMedCrossRef

86.

Sakahara H, Kiuchi T, Nishizawa S et al. Asialoglycoprotein receptor scintigraphy in evaluation of auxillary partial orthotopic liver transplantation. J Nucl Med 1999;40:1463–1467.PubMed

87.

Yokoyama Y, Nagino M, Nimura Y. Mechanism of impaired hepatic regeneration in cholestatic liver. J Hepatobiliary Pancreatic Surg 2007;14:159–166.CrossRef

88.

Xu C, Lin F, Qin S. Relevance between lipid metabolism-associated genes and rat liver regeneration. Hepatol Res 2008 (In Press).

89.

Zhang LX, Zhao LF, Zhang AS, Chen XG, Xu CS. Expression patterns and action analysis of genes associated with physiological responses during rat liver regeneration: Cellular immune response. World J Gastroenterol 2006;12:7514–7521.PubMed

90.

Zhao LF, Zhang WM, Xu CS. Expression patterns and action analysis of genes associated with blood coagulation responses during rat liver regeneration. World J Gastroenterol 2006;12:6842–6849.PubMed

91.

Li H, Chen XG, Zhang F, Ma J, Xu CS. Expression patterns of the cell junction-associated genes during rat liver regeneration. J Genet Genomics 2007;34:892–908.PubMedCrossRef

92.

Xu CS, Chang CF. Expression profiles of the genes associated with metabolism and transport of amino acids and their derivatives in rat liver regeneration. Amino Acids 2008;34:91–102.PubMedCrossRef

93.

Sun Y, Deng X, Li W et al. Liver proteome analysis of adaptive response in rat immediately after partial hepatectomy. Proteomics 2007;7:4398–4407.PubMedCrossRef

94.

Parent R, Beretta L. Proteomics in the study of liver pathology. J Hepatol 2005;43:177–183.PubMedCrossRef

Title: Quantitative Assessment of Hepatic Function and its Relevance to the Liver Surgeon
Authors: G. Morris-Stiff
D. Gomez
R. Prasad
Publication date: 01-02-2009
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 2/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-008-0564-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Quantitative Assessment of Hepatic Function and its Relevance to the Liver Surgeon

Abstract

Background

Methods

Results and Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results and Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2009

Complications Requiring Reoperation after Gastrectomy for Gastric Cancer: 17 Years Experience in a Single Institute

Intrapancreatic Accessory Spleen: Deficiency in Diagnosis or Therapeutic Success?

Re: Oelschlager BK, Yamamoto K, Woltman T, Pellegrini C. Vagotomy During Hiatal Hernia Repair: a Benign Esophageal Lengthening Procedure. J Gastrointest Surg. 2008;12(7):1155–62.

Prospective 6 Weeks Follow-up Post-cholecystectomy: The Predictive Value of Pre-Operative Symptoms

Reply to JGSU-D-08-00664: Intrapancreatic Accessory Spleen: Deficiency in Diagnosis or Therapeutic Success?

Functional Outcome After Restorative Proctocolectomy in Pigs: Comparing a Novel Transverse Ileal Pouch to the J-Pouch and Straight Ileoanal Anastomosis